Cargando…

HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis

BACKGROUND: Human papillomavirus (HPV) E6/E7 mRNA in situ hybridization (HPV E6/E7 RNAscope) appears to be a sensitive and specific technique in detecting transcriptionally active HPV. We aimed to examine the diagnostic utility of this technique in endocervical adenocarcinoma (ECA), to explore the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Rong-Zhen, Chen, Shu-Lin, Li, Mei, Li, Yue, Yang, Xia, Liu, Li-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641184/
https://www.ncbi.nlm.nih.gov/pubmed/34861873
http://dx.doi.org/10.1186/s12935-021-02349-1
_version_ 1784609456988880896
author Luo, Rong-Zhen
Chen, Shu-Lin
Li, Mei
Li, Yue
Yang, Xia
Liu, Li-Li
author_facet Luo, Rong-Zhen
Chen, Shu-Lin
Li, Mei
Li, Yue
Yang, Xia
Liu, Li-Li
author_sort Luo, Rong-Zhen
collection PubMed
description BACKGROUND: Human papillomavirus (HPV) E6/E7 mRNA in situ hybridization (HPV E6/E7 RNAscope) appears to be a sensitive and specific technique in detecting transcriptionally active HPV. We aimed to examine the diagnostic utility of this technique in endocervical adenocarcinoma (ECA), to explore the prognostic factors for ECA patients and develop a clinically useful nomogram based on clinicopathological parameters to predict it. METHODS: We retrospectively analyzed 200 patients with ECA who had undergone surgery at Sun Yat-sen University Cancer Center from 2010 and 2014. The diagnostic performance of HPV E6/E7 RNAscope were evaluated by receiver operating characteristic (ROC) curve. A prognostic nomogram model including HPV E6/E7 RNAscope was generated based on multivariate Cox regression analysis, then we compared the predictive accuracy of the prognostic model with FIGO staging and treatment using concordance index (C-index), time-dependent ROC (tdROC), and decision curve analysis (DCA). RESULTS: The sensitivity and specificity of HPV E6/E7 RNAscope for distinguishing HPV-associated adenocarcinoma (HPVA) from non-HPV-associated adenocarcinoma (NHPVA) in the whole cohort were 75.8% and 80%, respectively. According the univariate analysis and multivariate logistic regression analysis, age, lymphovascular invasion (LVI), lymph node involvement (LNI), and HPV E6/E7 RNAscope were valuable predictive factors for OS. These parameters were incorporated into the nomogram model (nomogram A) compared with FIGO stage and treatment. The C-index of nomogram A for predicting OS was 0.825, which was significantly higher than FIGO stage (C-index = 0.653, p = 0.002) and treatment (C-index = 0.578, p < 0.001). CONCLUSIONS:  HPV E6/E7 RNAscope is highly specific for ECA, and the 4-variable nomogram showed more accurate prognostic outcomes in patients with ECA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02349-1.
format Online
Article
Text
id pubmed-8641184
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86411842021-12-06 HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis Luo, Rong-Zhen Chen, Shu-Lin Li, Mei Li, Yue Yang, Xia Liu, Li-Li Cancer Cell Int Primary Research BACKGROUND: Human papillomavirus (HPV) E6/E7 mRNA in situ hybridization (HPV E6/E7 RNAscope) appears to be a sensitive and specific technique in detecting transcriptionally active HPV. We aimed to examine the diagnostic utility of this technique in endocervical adenocarcinoma (ECA), to explore the prognostic factors for ECA patients and develop a clinically useful nomogram based on clinicopathological parameters to predict it. METHODS: We retrospectively analyzed 200 patients with ECA who had undergone surgery at Sun Yat-sen University Cancer Center from 2010 and 2014. The diagnostic performance of HPV E6/E7 RNAscope were evaluated by receiver operating characteristic (ROC) curve. A prognostic nomogram model including HPV E6/E7 RNAscope was generated based on multivariate Cox regression analysis, then we compared the predictive accuracy of the prognostic model with FIGO staging and treatment using concordance index (C-index), time-dependent ROC (tdROC), and decision curve analysis (DCA). RESULTS: The sensitivity and specificity of HPV E6/E7 RNAscope for distinguishing HPV-associated adenocarcinoma (HPVA) from non-HPV-associated adenocarcinoma (NHPVA) in the whole cohort were 75.8% and 80%, respectively. According the univariate analysis and multivariate logistic regression analysis, age, lymphovascular invasion (LVI), lymph node involvement (LNI), and HPV E6/E7 RNAscope were valuable predictive factors for OS. These parameters were incorporated into the nomogram model (nomogram A) compared with FIGO stage and treatment. The C-index of nomogram A for predicting OS was 0.825, which was significantly higher than FIGO stage (C-index = 0.653, p = 0.002) and treatment (C-index = 0.578, p < 0.001). CONCLUSIONS:  HPV E6/E7 RNAscope is highly specific for ECA, and the 4-variable nomogram showed more accurate prognostic outcomes in patients with ECA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02349-1. BioMed Central 2021-12-03 /pmc/articles/PMC8641184/ /pubmed/34861873 http://dx.doi.org/10.1186/s12935-021-02349-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Luo, Rong-Zhen
Chen, Shu-Lin
Li, Mei
Li, Yue
Yang, Xia
Liu, Li-Li
HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
title HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
title_full HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
title_fullStr HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
title_full_unstemmed HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
title_short HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
title_sort hpv e6/e7 mrna in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641184/
https://www.ncbi.nlm.nih.gov/pubmed/34861873
http://dx.doi.org/10.1186/s12935-021-02349-1
work_keys_str_mv AT luorongzhen hpve6e7mrnainsituhybridizationinendocervicaladenocarcinomaimplicationsforprognosisanddiagnosis
AT chenshulin hpve6e7mrnainsituhybridizationinendocervicaladenocarcinomaimplicationsforprognosisanddiagnosis
AT limei hpve6e7mrnainsituhybridizationinendocervicaladenocarcinomaimplicationsforprognosisanddiagnosis
AT liyue hpve6e7mrnainsituhybridizationinendocervicaladenocarcinomaimplicationsforprognosisanddiagnosis
AT yangxia hpve6e7mrnainsituhybridizationinendocervicaladenocarcinomaimplicationsforprognosisanddiagnosis
AT liulili hpve6e7mrnainsituhybridizationinendocervicaladenocarcinomaimplicationsforprognosisanddiagnosis